View source for Walmart Target Quietly Exploring CBD Product Lines

<br>Big-box retailers aren’t selling CBD yet, but they’re busy getting ready for the day when they can. The Post has learned that top executives at major  [https://support.ourarchives.online/index.php?title=User:CynthiaOrtega35 Bliss Harmony™] chains such as Walmart and Target have been quietly meeting with makers of drinks, gummy bears, topical creams and oils that are infused with cannabidiol, or CBD. CBD is an ingredient in marijuana plants that doesn’t get you high, but is said to relieve pain as well as stress symptoms including anxiety and insomnia. The chains, which also include big supermarkets such as Kroger and Safeway, are requesting samples of CBD products, along with lab results and pricing information, manufacturers said. "We are flying around the country, talking to all the big guys at their headquarters," said Christian Graversen, brand manager of California-based CBDfx, a 6-year-old company that makes more than 50 CBD-infused products including a $10 package of eight gummy bears. "We are going multiple times to the same companies, meeting with their senior buyers, legal departments and merchandising executives," Graversen added.<br>[https://www.bing.com/?cc=ch bing.com]<br><br><br>Major retailers are angling for a piece of the exploding CBD industry, which is expected to more than double to $2.1 billion by next year as consumers pay premium prices for products to treat maladies ranging from arthritis to ADHD. Up to now, the lion’s share of the CBD bonanza has been going to mom-and-pop shops. But a few bigger chains, including Walgreens, CVS and GNC, have begun selling CBD-infused topical creams that treat wrinkles and pain in states where they’re allowed, including New York. "We do not have plans to carry CBD products at this time," Walmart said in a statement, declining to elaborate on its CBD strategy. "Like many companies, we know there is consumer interest in CBD products, and the conversation is evolving quickly," a Target spokesperson said. Nevertheless, both chains are not only doing due diligence on CBD but also hatching plans for how to sell it, sources said. CBD products will sit in their stores,  [http://test-www.writebug.com:3000/milanmoney2557 Bliss Harmony brand] but they aren’t buying any product yet," said Michael Kirban, chief executive of Vita Coco. The coconut water brand is planning to roll out a version of its drinks this summer infused with hemp, a non-psychoactive component of marijuana that last December got removed from a list of illegal substances under federal law with the signing of the US Farm Bill. But the rollout will likely be limited to smaller chains and stores, Kirban said. Bigger retailers are waiting on a permanent FDA ruling on marijuana-based products, which is not expected until the end of this year at the earliest.<br><br><br><br>CBD (cannabidiol) and THC (tetrahydrocannabinol) are the two major compounds found in the cannabis plant. Each has unique properties, potential health benefits, and side effects. The following article covers CBD and THC, their effects, their legal status, and their safety considerations. CBD and THC are known as cannabinoids. They have very similar chemical structures and activate the same receptors within the body’s endocannabinoid system. Despite their similarity in structure, CBD and THC exert entirely different effects. The most significant difference between these two compounds is that THC is psychoactive. This means it can affect how the brain works. THC activates the body’s "reward" pathways to produce the "high" that’s associated with marijuana use. It does this by activating a cannabinoid receptor called CB1. When THC activates this type of receptor, things like movement, body temperature, and brain function are affected. In contrast, [https://linktree.biz/edgardocal BlissHarmony CBD] is not considered psychoactive. It does not cause euphoria or a "high," even at large doses.<br><br><br><br>Much of the research on CBD and THC is preclinical, meaning it’s been studied in animal models. Large-scale human trials are necessary to determine if CBD or THC can help treat most of these conditions. Though it does act on cannabinoid receptors, CBD mainly affects other receptors, including serotonin receptors. It may help counteract some of the negative effects of THC, including serious side effects like psychosis. CBD has many purported therapeutic properties. Pain. Overall, there isn’t enough evidence that CBD by itself helps with pain. Some research has shown that high doses can improve neuropathy (nerve pain), though more data is necessary. Anxiety. So far, the results are mixed. Some studies show that CBD can improve symptoms of social anxiety disorder and post-traumatic stress disorder (PTSD), while others show no effect. Seizures. Epidiolex, a purified CBD oil, is approved by the Food and Drug Administration (FDA) for some hard-to-treat types of childhood epilepsy.<br>